PPARD and neoplasm: FASN was also shown to be an upstream regulator of peroxisome proliferator-activated receptor gamma (PPAR)-β/δ in myeloid cells, and myeloid cell-specific PPAR-β/δ knockout reduced tumor burden (Park et al., 2015).